http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001137327-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-16 |
| filingDate | 1999-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf778b96673c8118e9446e0d13ef2e8 |
| publicationDate | 2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001137327-A |
| titleOfInvention | Liquid wound dressing |
| abstract | (57) [Summary] [Problem] Since it is in a liquid state before application, it can be easily applied to an affected part of any shape. Immediately after application, it quickly cures when it comes into contact with body fluids, so that it has excellent operability and is formed after curing. The substance is excellent in biocompatibility and biodegradability and is flexible, so that it does not hinder the natural healing of the injured part, and has effects such as inter-tissue adhesion, tissue replenishment, tissue repair, adhesion prevention, hemostasis, wound surface protection, wound surface closure, etc. The provision of a liquid wound dressing exhibiting the following. SOLUTION: Collagen of 1 to 100 g / L and 0. A liquid wound dressing containing 1 to 100 mmol / L acid. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112940302-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014507135-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137166-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112940302-A |
| priorityDate | 1999-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.